The 30 breast cancer cell lines were divided into two groups based on the level of PARP1 mRNA, and those with a high level of PARP1 demonstrated a tendency to have a higher palbociclib IC50 (Fig. 1H). The gene discussed is PARP1; the disease is breast carcinoma.